8-Methoxy-4-oxo-2,3-dihydro-1H-cyclopentachinolin | 4562-55-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 8-Methoxy-4-oxo-2,3-dihydro-1H-cyclopentachinolin
• 英文别名: 8-methoxy-1,2,3,5-tetrahydro-cyclopenta[c]quinolin-4-one；8-Methoxy-1,2,3,5-tetrahydrocyclopenta[c]quinolin-4-one
• CAS: 4562-55-4
• 化学式: C₁₃H₁₃NO₂
• 分子量: 215.252
• InChiKey: AAIRXTJUNOKVMC-UHFFFAOYSA-N

物化性质

• 熔点：
  256 °C
• 沸点：
  451.0±45.0 °C(Predicted)
• 密度：
  1.26±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  8-Methoxy-4-oxo-2,3-dihydro-1H-cyclopentachinolin 在 劳森试剂 、 甲醇 、 氨 、 magnesium 作用下， 以 乙二醇二甲醚 为溶剂， 生成 (3aS,9bR)-8-Methoxy-2,3,3a,9b-tetrahydro-1H-cyclopenta[c]quinolin-4-ylamine
  参考文献：
  名称：

  Dihydroquinolines as Novel n-NOS Inhibitors

  摘要：

  Dihydroquinolines have been synthesized and have been shown to be potent n-NOS inhibitors. Selectivity versus e-NOS was increased to approximately 100-fold through appropriate substitution at the benzene ring. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00481-x
• 作为产物：
  描述：

  2-[2-(2,2-Dimethyl-propionylamino)-5-methoxy-phenyl]-cyclopent-1-enecarboxylic acid methyl ester 在 盐酸 作用下， 生成 8-Methoxy-4-oxo-2,3-dihydro-1H-cyclopentachinolin
  参考文献：
  名称：

  Dihydroquinolines as Novel n-NOS Inhibitors

  摘要：

  Dihydroquinolines have been synthesized and have been shown to be potent n-NOS inhibitors. Selectivity versus e-NOS was increased to approximately 100-fold through appropriate substitution at the benzene ring. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00481-x

文献信息

• [EN] TRYCYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME<br/>[FR] COMPOSÉS TRICYCLIQUES ET INHIBITEURS DE PBK LES CONTENANT
  申请人：ONCOTHERAPY SCIENCE INC

  公开号：WO2011123419A1

  公开（公告）日：2011-10-06

  Trycyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.

  提供的是三环化合物。这些化合物是PBK抑制剂，可用于治疗与PBK相关的疾病，包括癌症。
• 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors
  申请人：Schering Aktiengesellschaft

  公开号：US06391887B1

  公开（公告）日：2002-05-21

  The invention relates to compounds of formula (I), as defined herein. The invention also relates to the use of the inventive compounds for treatment of a disease caused by the effects of nitrogen monoxide in pathological conditions.

  该发明涉及公式（I）所定义的化合物。该发明还涉及将这些创新化合物用于治疗由氮氧化物在病理条件下引起的疾病。
• [EN] HETEROCYCLIC SUBSTITUTED PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA<br/>[FR] PIPERAZINES HETEROCYCLIQUES SUBSTITUEES POUR LE TRAITEMENT DE LA SCHIZOPHRENIE
  申请人：WARNER LAMBERT CO

  公开号：WO2004026864A1

  公开（公告）日：2004-04-01

  This invention relates to compounds of the formula 1 wherein X, Y, Z, A, R', R2, R3, R4, R9, W' and W2 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other disorders.

  本发明涉及式1的化合物，其中X、Y、Z、A、R'、R2、R3、R4、R9、W'和W2如规范中定义，包含它们的药物组合物以及它们在治疗中枢神经系统和其他疾病中的用途。
• ANTI-VIRAL COMPOUNDS
  申请人：McDaniel Keith F.

  公开号：US20100168384A1

  公开（公告）日：2010-07-01

  Compounds capable of inhibiting replication of the hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

  本发明描述了一种能够抑制丙型肝炎病毒（“HCV”）复制的化合物。本发明还涉及制造此类化合物的方法，含有此类化合物的组合物以及使用此类化合物治疗HCV感染的方法。
• TRICYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME
  申请人：Nakamura Yusuke

  公开号：US20130178459A1

  公开（公告）日：2013-07-11

  Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.

  提供三环化合物。这些化合物是PBK抑制剂，可用于治疗与PBK相关的疾病，包括癌症。